Compositions, kits and methods for the diagnosis, prognosis, and monitoring of cancer using GOLPH3

Details for Australian Patent Application No. 2009298150 (hide)

Owner Dana-Farber Cancer Institute, Inc.

Inventors Chin, Lynda; Scott, Kenneth; Kabbarah, Omar

Agent FB Rice

Pub. Number AU-A-2009298150

PCT Pub. Number WO2010/040124

Priority 61/217,688 03.06.09 US; 61/217,768 04.06.09 US; 61/195,071 03.10.08 US; 61/217,502 01.06.09 US

Filing date 5 October 2009

Wipo publication date 8 April 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

14 April 2011 PCT application entered the National Phase

  PCT publication WO2010/040124 Priority application(s): WO2010/040124

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009298151-Systems and methods for automatic creation of agent-based systems

2009298139-Compositions and methods for the treatment of bowel diseases with granulated mesalamine